Standout Papers
- New Guidelines to Evaluate the Response to Treatment in Solid Tumors (2000)
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics (2017)
- RECIST 1.1—Update and clarification: From the RECIST committee (2016)
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer (2006)
- Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma (2002)
Immediate Impact
3 by Nobel laureates 6 from Science/Nature 116 standout
Citing Papers
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
2021 StandoutNature
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Works of Patrick Therasse being referenced
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
2017 Standout
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
2000 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Patrick Therasse | 10686 | 3726 | 8536 | 36 | 20.2k | |
| Stephen J. Gwyther | 12130 | 3702 | 10068 | 30 | 22.7k | |
| E. Eisenhauer | 11648 | 3600 | 9540 | 62 | 22.0k | |
| Margaret Mooney | 11837 | 3806 | 9599 | 61 | 22.3k | |
| P. Therasse | 12124 | 4099 | 10292 | 57 | 23.4k | |
| Michaele C. Christian | 9333 | 2671 | 6876 | 47 | 18.2k | |
| Allan T. van Oosterom | 9266 | 2777 | 10029 | 88 | 21.6k | |
| Lalitha Shankar | 13358 | 4287 | 11141 | 80 | 26.2k | |
| J. Wanders | 10960 | 2723 | 7888 | 132 | 19.3k | |
| Jan Bogaerts | 15815 | 6899 | 11721 | 113 | 29.2k | |
| William Novotny | 12249 | 3694 | 5513 | 109 | 22.1k |
All Works
Loading papers...